facebook tracking

Free Patient Webinar

Know What Your Doctors Know: Multiple Myeloma

Multiple Myeloma experts provide information and answer questions on how multiple myeloma is diagnosed and staged, treatment options, recent advances in care, and supportive care resources.


Click the play button above to view the Know What Your Doctors Know: Multiple Myeloma videos playlist or select an individual video within the playlist menu in the top left corner of the video window or from the list below.

View the full video of the webinar.

Part 1 - About NCCN and NCCN Foundation
Part 2 - Presenters
Part 3 - Challenges of Diagnosis
Part 4 - Initial Treatment   
Part 5 - Stem Cell Transplants
Part 6 - Advances in Treatment
Part 7 - Managing Symptoms
Part 8 - Side Effects of Treatment
Part 9 - The Right Track
Part 10 - Clinical Trials
Part 11 - Resources
Q&A - Dexamethasone
Q&A - Serum beta-2 microglobulin
Q&A - Role of heredity in myeloma
Q&A - Daratumumab as a monotherapy for myeloma
Q&A -  Bisphosphonates
Q&A -  Abnormal free light chains
Q&A -  Prognostic value of the kappa lambda ratio
Q&A -  Monoclonal gammopathy of renal significance (MGRS)
Q&A -  Lab tests used to monitor MGUS
Q&A -  Drug reactions
Q&A - Support system for bone marrow transplant patients
Q&A -  Proteasome inhibitor-associated blepharitis
Q&A -  Role of MRI in MGUS or smoldering myeloma
Q&A -  CAR-T cells
Q&A -  Osteonecrosis of the jaw (ONJ)
Q&A -  Length of treatment
Q&A -  Take-home points for primary care physicians
Q&A -  Enrollment in clinical trials
Q&A -  Bone lesions
Q&A -  Monitoring response to treatment
Q&A -  Bactrim for urinary tract infections (UTIs)
Q&A -  The role of x-ray in the identification and diagnosis of myeloma
Q&A -  More on the role of heredity in myeloma
Q&A -  Average age of onset or diagnosis
Q&A -  The M spike and light chain myeloma

The Know What Your Doctors Know: Multiple Myeloma webinars occurred in April 2019. This informational program was created in conjunction with the recently updated NCCN Guidelines for Patients® for Multiple Myeloma.

The NCCN Guidelines for Patients sheets are available to read and download for free online and via the NCCN Patient Guides for Cancer mobile app. Printed editions can be ordered from Amazon.com for a small fee.

NCCN Guidelines for Patients and NCCN Quick Guide™ sheets DO NOT replace the expertise and clinical judgment of the clinician.


This activity is supported through the NCCN Foundation, by a contribution from our industry supporter Amgen. NCCN independently develops and distributes the NCCN Guidelines for Patients. Our industry supporters do not participate in the development of the NCCN Guidelines for Patients and are not responsible for the content and recommendations contained therein.

The NCCN Guidelines for Patients: Multiple Myeloma are endorsed by:

The Leukemia & Lymphoma Society (LLS)
Multiple Myeloma Research Foundation (MMRF)
Blood & Marrow Transplant Information Network (BMT InfoNet)
National Bone Marrow Transplant Link (nbmtLINK)